INSR and Parkinson disease: Since the HIRMAb domain of the HIRMAb-GDNF fusion protein does not recognize the murine insulin receptor (Zhou et al., 2012), mice with experimental PD were treated with an IgG-GDNF fusion protein that is active in the mouse.